Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Adaptive Statistical Analysis and Continuous Inference Framework

Open
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled Adaptive Statistical Analysis and Continuous Inference Framework, supports prime contractors on ARPA-H projects under the Department of Health and Human Services. The primary objective is the development and implementation of validated statistical and regulatory frameworks for continuous inference. This includes the integration of adaptive elements such as response-adaptive randomization, sample size re-estimation, and specific stopping rules for safety, efficacy, and futility. To ensure regulatory compliance, all deliverables must align with FDA, CBER, and CDER standards for adaptive trials. The final output of the contract will be a validated statistical framework and a set of adaptive decision rules. The solicitation was posted on September 30, 2026, with a response deadline of November 30, 2026, falling under NAICS code 541690.

General Info

Subcontract for developing FDA-compliant adaptive statistical frameworks and continuous inference for ARPA-H projects.

NAICS

541690 - Other Scientific and Technical Consulting Services

Place of Performance

DC

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SOL-26-164.

The full solicitation package (4 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Due in 15 days

Read the full solicitation package

This scope is part of a larger contract. Its documents live on the prime.

  • 4 documents on the prime contractFrom Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Read the prime's documents

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs development of validated statistical and regulatory frameworks for continuous inference for prime contractors on ARPA-H projects. Implements adaptive elements including futility, efficacy, and safety stopping rules, sample size re-estimation, and response-adaptive randomization. Aligns with FDA/CBER/CDER standards for adaptive trials. Delivers a validated statistical framework and adaptive decision rules.

Similar Contracts

Same NAICS industry code

NAICS: 541690
New
International
Study of Global Navigation Satellite Systems Disruption in the Energy Sector [Étude sur les perturbations des systèmes mondiaux de satellites de navigation, dans le secteur de l’énergie]
Solicitation # WS5980553072
Public Services and Procurement Canada, on behalf of Natural Resources Canada, is soliciting proposals for a comprehensive study to assess the Canadian energy sector's dependence on Global Navigation Satellite Systems (GNSS). The project aims to identify the impacts of potential disruptions to Positioning, Navigation, and Timing (PNT) data, specifically accounting for regional differences in energy infrastructure and regulatory frameworks. The successful contractor will generate research, analytical products, and stakeholder guidance to develop mitigation strategies and resilience solutions. All final deliverables must be submitted by March 31, 2027, with the performance period divided into two phases: an initial 25-week period followed by a subsequent 16-week period. Bids must be submitted via the SAP Business Network by December 14, 2026, at 2 pm EST. The contract will be awarded based on a weighted evaluation consisting of 70% technical merit and 30% price. Proposals must be organized into three distinct sections: a Technical Offer, a Financial Offer, and a Submission/Declaration Form. The project is classified as unclassified, though the contractor must maintain strict confidentiality of all client information and adhere to Canadian law. Evaluation of the work will be conducted by the government, with the right to inspect deliverables at the contractor's facilities, and the contractor is required to maintain accurate inspection records for three years following the contract's conclusion.
Government of Canada / Gouvernement du Canada

POSTED

3 days ago

DEADLINE

in 28 days
View Details
NAICS: 541690
New
International
Actuarial Costing and Return on Investment Analysis for the Modernization of the Federal Workers’ Compensation Regime
Solicitation # 100032367
The Department of Employment and Social Development for the Government of Canada is seeking an independent actuarial costing analysis to evaluate the direct and indirect costs of the federal workers compensation regime. The objective is to compare the costs of maintaining the current regime against two proposed modernization options, including a return on investment analysis. This study will focus on overall regime costs, the five federal employers with the highest claim volumes, and a selection of employers with moderate claim volumes. The contract has a maximum funding ceiling of 750,000.00 CAD and a performance period extending 12 months after the award. The project is divided into three key milestones: a Progress Report due March 31, 2027, a Draft Report and Presentation due ten months after award, and a Final Report due twelve months after award. Payment is structured as 25 percent for the first two deliverables and 50 percent for the final report. To be eligible, the lead resource must be a Fellow of the Canadian Institute of Actuaries. Selection is based on the highest rated bid within budget, requiring a minimum technical score of 71 out of 100 points. All deliverables must be submitted in English and adhere to ETSI EN 301 549 accessibility standards.
Department of Employment and Social Development

POSTED

3 days ago

DEADLINE

in 14 days
View Details

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541714
New
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

3 days ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Solicitation # ARPA-H-SOL-26-163
The Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, issued by the Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office under solicitation ARPA-H-SOL-26-163, seeks innovative solutions to identify and act upon autism trajectories across the lifespan. The program focuses on the nonlinear interactions of genetic, biological, behavioral, and environmental factors to move toward personalized care. The scope is divided into four Technical Areas: TA1 focuses on multi-factor analysis and trajectory identification; TA2 involves population-scale modeling and data integration; TA3 centers on precision intervention and trajectory testing; and TA4 targets technologies for communication, quality of life, and embedded assessment. Awards will be made using Other Transaction (OT) instruments through a two-stage submission process consisting of a Solution Summary and a Full Proposal. Technical performance is monitored via a milestone-based system with evaluation gates at Month 10, Month 22, and a final evaluation at Month 46. Key requirements include strict adherence to HIPAA Privacy Rule de-identification standards, the implementation of independent data safety monitoring boards for harm surveillance, and the disclosure of any organizational conflicts of interest. Submissions must follow specific formatting guidelines, including the use of Avenir Next LT Pro font for summaries and a multi-volume structure for full proposals, with a response deadline of December 2, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 16 days
View Details
NAICS: 541714
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, seeks to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. This opportunity is open to researchers from academic, nonprofit, and industry organizations, provided the Principal Investigator is within eight years of completing their first terminal degree. The initiative covers 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. Awards are issued as Other Transaction (OT) agreements, which are not subject to the Federal Acquisition Regulation (FAR). The selection process is a two-step submission involving an initial anonymized Solution Summary and a subsequent Full Proposal for selected candidates. Successful awards have a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a 24-month base period capped at 700,000 dollars and an optional 12-month Director's Award period capped at 350,000 dollars. Payments are structured as fixed payments triggered by the completion of 12 discrete, measurable milestones. Full proposals are evaluated based on technical merit, innovativeness, feasibility, alignment with the ARPA-H mission to accelerate health outcomes, and price reasonableness. Administrative requirements include mandatory registration in SAM.gov and the use of the ARPA-H Solutions site for all submissions. Proposers must adhere to strict formatting templates for technical and management proposals, milestone schedules, and national policy requirements, including disclosures regarding organizational conflicts of interest and research security. Performance is monitored through a formal inspection and acceptance process where the government reviews deliverables within 14 calendar days. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

25 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the UNifying Imaging with QUantum Entanglement (UNIQUE) program, solicitation number ARPA-H-SOL-26-162. This 18-month, two-phase initiative aims to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data using quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: the Imaging Core, which focuses on physical systems for generating and measuring quantum observables, and the Computational Foundation, which focuses on AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction Agreements to eligible universities, non-profit organizations, and businesses. The submission process is two-staged, requiring Solution Summaries by late October 2026 and Full Proposals by December 15, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on technical innovation and feasibility, proposer expertise, potential to transform biomedicine, and cost reasonableness. Notably, for-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. All participants must adhere to strict HHS regulations regarding human stem cell research and prohibitions on dangerous gain-of-function research and funding for foreign entities in countries of concern.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 2 months ago

DEADLINE

in 30 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS